SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-089753
Filing Date
2024-08-14
Accepted
2024-08-14 17:24:33
Documents
1
Period of Report
2024-08-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2421731-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2421731-1_3seq1.xml 3 8778
  Complete submission text file 0001104659-24-089753.txt   10416
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address
Banjak Marc (Reporting) CIK: 0002033869 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35023 | Film No.: 241209650